Marketable Securities

3 Months Ended

Mar. 31, 2022

Marketable Securities

Marketable Securities

6. Marketable Securities

Marketable securities in equity securities with readily determinable market prices consisted of the following as of March 31, 2022 and December 31, 2021:

	Marketable equity securities at March 31, 2022
			Gross unrealized		Gross unrealized
	Cost		gains		losses			Fair value
Common shares	$	16,366,000	$	5,268,000	$	(5,476,000	)	$	16,158,000

	Marketable equity securities at December 31, 2021
			Gross unrealized		Gross unrealized
	Cost		gains		losses			Fair value
Common shares	$	53,475,000	$	32,000	$	(13,127,000	)	$	40,380,000

At March 31, 2022 and December 31, 2021, the Company invested in the marketable equity securities of publicly traded companies. The Company’s investment in marketable equity securities are revalued on each balance sheet date.